List of insiders holdings for CTI BIOPHARMA CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Baxter Healthcare SA 10% Owner | 2015-05-01 17:23:07 | 15,673,981 0 | 15,673,981 | Form 4 |
Baxter Healthcare SA BAXTER INTERNATIONAL INC 10% Owner | 2015-05-01 17:21:35 | 15,673,981 0 | 15,673,981 | Form 13G |
BIANCO JAMES A Director | 2016-10-03 20:39:14 | 6,539,290 0 | 6,539,290 | Form 4 |
ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 2021-12-06 16:25:16 | 4,024,821 0 | 4,024,821 | Form 13G |
ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ISALY SAMUEL D 10% Owner | 2021-12-06 16:25:16 | 4,024,821 0 | 4,024,821 | Form 13G |
BENNER STEVEN E EVP, Chief Medical Officer | 2013-03-22 17:53:27 | 616,809 33,334 | 650,143 | Form 4 |
BIANCO LOUIS A EVP, Finance & Administration | 2016-03-23 18:36:46 | 622,933 37 | 622,970 | Form 4 |
GREGORIAN VARTAN Director | 2014-03-28 18:41:16 | 468,937 0 | 468,937 | Form 4 |
MUNDINGER MARY ONEIL Director | 2016-04-29 17:45:19 | 360,019 0 | 360,019 | Form 4 |
Eramian Daniel G EVP, Corporate Communications | 2012-09-21 19:35:26 | 354,350 0 | 354,350 | Form 4 |
SEELEY BRUCE J. EVP, Chief Operating Officer | 2022-03-11 19:40:31 | 323,905 0 | 323,905 | Form 4 |
SPINELLI SILVANO EVP, Development | 2005-03-02 17:08:04 | 125,000 0 | 125,000 | Form 4 |
SINGER JACK W EVP, Chief Scientific Officer | 2018-05-17 16:25:09 | 94,433 0 | 94,433 | Form 4 |
LOVE RICHARD L Director | 2017-10-02 17:25:03 | 73,718 0 | 73,718 | Form 4 |
LINK MAX Director | 2005-10-04 18:33:31 | 73,572 0 | 73,572 | Form 4 |
NUDELMAN PHILLIP M PHD Director | 2017-05-02 17:46:37 | 73,129 0 | 73,129 | Form 4 |
STROMATT SCOTT EVP,Clinical Dev & Reg Affair | 2008-04-08 17:30:51 | 65,786 0 | 65,786 | Form 4 |
Ignagni Karen Director | 2015-09-25 18:18:57 | 63,695 0 | 63,695 | Form 4 |
BAUER JOHN H Director | 2015-09-25 18:33:01 | 63,695 0 | 63,695 | Form 4 |
Plunkett Matthew EVP, Chief Business Officer | 2017-03-06 16:59:06 | 60,000 0 | 60,000 | Form 4 |
Telling Fred Director | 2018-09-20 16:23:02 | 60,000 0 | 60,000 | Form 4 |
CANFIELD JAMES Chief Administrative Officer | 2005-04-05 20:59:26 | 39,499 0 | 39,499 | Form 4 |
KENNEY EDWARD F EVP, Chief Operating Officer | 2004-01-05 18:27:04 | 25,374 0 | 25,374 | Form 4 |
SUTTER MARTIN P Director | 2003-11-14 14:36:34 | 25,000 0 | 25,000 | Form 4 |
ASELAGE STEVE EVP, Global Commercial Ops | 2005-07-05 20:30:14 | 24,133 0 | 24,133 | Form 4 |
Leigh Richard JR EVP, General Counsel | 2005-09-15 17:06:30 | 13,300 0 | 13,300 | Form 4 |
Brown Jade EVP, Chief Business Officer | 2006-10-30 19:31:08 | 10,667 0 | 10,667 | Form 4 |
FLUKE JOHN M JR Director | 2005-03-16 18:19:23 | 10,000 0 | 10,000 | Form 4 |
PLATZER ERICH Director | 2005-01-04 19:44:04 | 10,000 0 | 10,000 | Form 4 |
BOWMAN JACK L Director | 2004-04-23 17:38:40 | 10,000 0 | 10,000 | Form 4 |
PHILIPS CRAIG Former President | 2012-11-19 21:07:09 | 414 0 | 414 | Form 4 |
BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks 10% Owner | 2023-06-28 18:26:13 | 0 0 | 0 | Form 4 |
PERRY MATTHEW D Director | 2023-06-26 16:05:42 | 0 0 | 0 | Form 4 |
Parks Diane L. Director | 2023-06-26 16:05:38 | 0 0 | 0 | Form 4 |
Fischer Laurent Director | 2023-06-26 16:05:31 | 0 0 | 0 | Form 4 |
Tuckson Reed Vaughn Director | 2023-06-26 16:05:25 | 0 0 | 0 | Form 4 |
Metzger Michael A Director | 2023-06-26 16:05:23 | 0 0 | 0 | Form 4 |
Parkinson David Ross Director | 2023-06-26 16:05:21 | 0 0 | 0 | Form 4 |
KIRSKE DAVID EVP, Chief Financial Officer | 2023-06-26 16:05:21 | 0 0 | 0 | Form 4 |
Craig Adam R President and CEO | 2023-06-26 16:05:16 | 0 0 | 0 | Form 4 |
Fong James K EVP & Chief Commercial Officer | 2023-06-26 16:05:10 | 0 0 | 0 | Form 4 |